GLAXOSMITHKLINE BIOLOGICAL SA

Patent Applications and Registrations

Patent applications and USPTO patent grants for GLAXOSMITHKLINE BIOLOGICAL SA.The latest application filed is for "detection of prame gene expression in cancer".

Company Profile

12.8.1

GLAXOSMITHKLINE BIOLOGICAL SA - Rixensart BE
GLAXOSMITHKLINE BIOLOGICAL SA - N/A
GlaxoSmithKline Biological S.A. - Rixensart BE
GLAXOSMITHKLINE BIOLOGICAL S.A. - BE BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Virion-like delivery particles for self-replicating RNA molecules Grant 11,291,635 - Geall , et al. April 5, 2	2022-04-05
Imidazoquinoline derivatives and their use in therapy Grant 11,274,115 - Bazin-Lee , et al. March 15, 2	2022-03-15
Methods of host cell modification Grant 11,220,676 - Wacker , et al. January 11, 2	2022-01-11
Adjuvanted combinations of meningococcal factor H binding proteins Grant 10,596,246 - Arico , et al.	2020-03-24
Methods and compositions for immune protection against extra-intestinal pathogenic E. coli Grant 10,583,185 - Poolman , et al.	2020-03-10
Process for producing influenza vaccine Grant 10,398,771 - D'Hondt , et al. Sep	2019-09-03
Methods and compositions relating to CRM197 Grant 10,287,330 - Ihssen , et al.	2019-05-14
Detection Of Prame Gene Expression In Cancer App 20140205635 - Minguet; Catherine	2014-07-24
Polypeptides and polynucleotides BASB040 from neisseria meningitidis and vaccine comprising said polypeptides and polynucleotides Grant 6,770,284 - Ruelle August 3, 2	2004-08-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.